NEU 3.32% $20.52 neuren pharmaceuticals limited

intrrepid-phase 111 trial., page-3

  1. 10,009 Posts.
    Nz 2566 is addressing ten differrant indications. The market siz e being addressed must be massive. With stroke, cardiac arrest and traumatic brain injury being just three of them.

    The Traumatic Brain Injury was estimated to be worth in excess of $200 million in the US.

    brain Injury also occurs during some Heart Bipass opersations.

    The cardiac and Stroke markets should be much bigger than TBI.

    PoS
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.